Register entryRepackager / relabeller
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- India
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| KAKSHAL | FIRST FLOOR,LOHCHWAN ROAD,SERVICE STATION,MANDIANA,140701, PATIALA, PUNJAB 140701, India (IND) | Relabelling | 3048513092771974793 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Kakshal Permethrin | Permethrin | lotion, topical | 87544-8526OTC MONOGRAPH DRUG |
Compare
Comparable companies in India
- Cutyx Research LLP1 site · 14 NDC
Enquiry
Common questions
- Is KAKSHAL FDA approved?
- KAKSHAL holds 1 FDA-registered establishment in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are KAKSHAL's registered sites?
- The FDA register lists PATIALA. Registered operations: relabelling.
- What drugs does KAKSHAL make?
- 1 product is listed under KAKSHAL in the openFDA NDC Directory, most often as lotion. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.